Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia
2011

Dexamethasone Reduces ROS Production in Microglia

publication Evidence: moderate

Author Information

Author(s): Huo Yingqian, Rangarajan Parakalan, Ling Eng-Ang, Dheen S Thameem

Primary Institution: Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore

Hypothesis

Dexamethasone inhibits Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia.

Conclusion

Dexamethasone may provide a therapeutic strategy for treating neuroinflammation by downregulating Nox-2 and upregulating MKP-1.

Supporting Evidence

  • Dexamethasone suppressed the upregulation of Nox-2 and iNOS in activated BV-2 cells.
  • Inhibition of MAPKs by dexamethasone was mediated by MKP-1.
  • Knockdown of Nox-2 reduced ROS production in BV-2 cells.

Takeaway

Dexamethasone helps calm down brain cells that get too excited and produce harmful substances, which can help in brain diseases.

Methodology

The study used BV-2 microglial cells treated with LPS and dexamethasone to measure ROS production and Nox-2 expression.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2202-12-49

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication